The immune system is designed to protect us against viruses and bacteria. In autoimmune diseases, however, the immune system ...

At its Navy Yard manufacturing facility, Iovance Biotherapeutics is transforming patients’ immune cells into lifesaving ...

Pharmac estimates the new approach will save approximately 3,700 infusion hours annually, easing pressure on oncology ...

From May 1, people with chronic lymphocytic leukaemia will be able to access combination treatments of venetoclax with either ibrutinib or obinutuzumab.

Booking Health, a global medical travel provider, announced today the release of its 2026 report on advanced head and neck ...

Enrolling Phase 2 DAYBreak CLL-201 bexobrutideg trial designed to support Accelerated Approval in relapsed/refractory chronic lymphocytic ...

CAR-T cell therapies advance the treatment of cancer, but they are expensive and can take weeks to process. Academic ...

A New Jersey oncology nurse explains how 'step therapy' forces cancer patients to try cheaper drugs first — and why that ...

Iovance chose Philadelphia for its manufacturing operations because of the region's proximity to airports and history of ...

As treatment options expand in chronic lymphocytic leukemia (CLL), the benefits and limitations of fixed-duration regimens in ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

Patients with chronic lymphocytic leukemia show higher risks for skin cancer, as well as skin cancer-specific metastasis and ...